TRAWS PHARMA INC (TRAW) Stock Price, Quote, News and Overview
NASDAQ:TRAW - Nasdaq - US68232V8845 - Common Stock - Currency: USD
TRAW Quote, Performance and Key Statistics
TRAWS PHARMA INC
NASDAQ:TRAW (2/5/2025, 8:00:01 PM)
After market: 8.16 +0.35 (+4.48%)7.81
+0.14 (+1.83%)
The current stock price of TRAW is 7.81 USD. In the past month the price decreased by -13.89%.
TRAW Latest News, Press Releases and Analysis
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu
/PRNewswire/ -- Traws Pharma, Inc. (NASDAQ: TRAW) ("Traws Pharma", "Traws" or "the Company"), a clinical-stage biopharmaceutical company developing oral small...
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program
/PRNewswire/ -- Expert Systems, a hybrid AI enabled drug discovery and development accelerator, announced a significant milestone in a development of Traws...
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval
/PRNewswire/ -- Traws Pharma, Inc. (NASDAQ: TRAW) ("Traws Pharma", "Traws" or "the Company"), a clinical-stage biopharmaceutical company developing oral small...
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
/PRNewswire/ -- Traws Pharma, Inc. (NASDAQ: TRAW) ("Traws Pharma", "Traws" or "the Company"), a clinical-stage biopharmaceutical company developing oral small...
TRAW Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 82.81 | 799.50B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 29.06 | 380.66B | ||
| JNJ | JOHNSON & JOHNSON | 15.48 | 372.43B | ||
| MRK | MERCK & CO. INC. | 11.74 | 226.83B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.62 | 219.98B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.86 | 219.54B | ||
| PFE | PFIZER INC | 8.5 | 149.84B | ||
| SNY | SANOFI-ADR | 13.51 | 134.13B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 51.03 | 121.10B | ||
| ZTS | ZOETIS INC | 30.5 | 79.26B | ||
| GSK | GSK PLC-SPON ADR | 9.11 | 76.92B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.09 | 42.39B |
Related stock screener links
About TRAW
Company Profile
Traws Pharma Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Newtown, Pennsylvania and currently employs 16 full-time employees. The company went IPO on 2013-07-25. Traws Pharma, Inc., formerly Onconova Therapeutics, Inc., is a virology and oncology company. The firm is engaged in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Its proprietary portfolio includes, TRX100 (viroksavir), TRX01 (travaltrevir), and Narazaciclib. Viroksavir is a cap-dependent endonuclease inhibitor for influenza. Travaltrevir is a Mpro protease inhibitor for COVID19. Narazaciclib is a cyclin-dependent kinases (CDK) 4/6 inhibitor for low-grade endometrioid endometrial cancer (LGEEC). Narazaciclib’s mechanism of action in LGEEC is validated by phase II studies with other approved CDK4/6 inhibitors: palbociclib, ribociclib, and abemaciclib. Narazaciclib is in phase I/IIa study to define the Phase II dose (RP2D).
Company Info
TRAWS PHARMA INC
12 Penns Trail
Newtown PENNSYLVANIA US
Employees: 16
Company Website: https://www.onconova.com/
Investor Relations: https://investor.onconova.com/
Phone: 12677593680
TRAW FAQ
What is the stock price of TRAW?
The current stock price of TRAW is 7.81 USD.
What is the symbol for TRAWS PHARMA INC stock?
The exchange symbol of TRAWS PHARMA INC is TRAW and it is listed on the Nasdaq exchange.
On which exchange is TRAW stock listed?
TRAW stock is listed on the Nasdaq exchange.
Is TRAW a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TRAW, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TRAW.
Does TRAW stock pay dividends?
TRAW does not pay a dividend.
What is the Price/Earnings (PE) ratio of TRAW?
TRAW does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.9).
What is the Short Interest ratio of TRAW stock?
The outstanding short interest for TRAW is 8.11% of its float.
TRAW Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to TRAW.
TRAW Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to TRAW. TRAW may be in some trouble as it scores bad on both profitability and health.
TRAW Financial Highlights
Over the last trailing twelve months TRAW reported a non-GAAP Earnings per Share(EPS) of -0.9. The EPS decreased by 1.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1575.48% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TRAW Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to TRAW. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -17393% and a revenue growth 6.81% for TRAW